drugset / Trial / NCT01475331

The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

NCT01475331

Phase 2 Completed 46 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of a chemotherapeutic cocktail with or without prior ethanol lavage for ablation of premalignant pancreatic cysts using endoscopic ultrasound-guided fine needle injection (EUS-FNI) for agent delivery.

Timeline

Start
2011-11
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alcohol Other / unclassified 80 % Other
Subject Gemcitabine Small molecule 19 mg/ml Other
Subject Paclitaxel Small molecule 3 mg/ml Other